Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 178

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 178
---
 the Merger Agreement in a manner
that would reasonably be expected to prevent (A) the Corporate Mergers, taken together, from qualifying as a “reorganization” within the meaning of Section 368(a) of the Code or (B) the delivery to Clearwater and Enfusion of
the Opinions by their respective Tax Counsels on the Closing Date, but before the Effective Time, then (x) the TRA Amendment will be void and will have no further force and effect, (y) the TRA will be deemed not to have been amended by the
TRA Amendment and (z) any Tax Benefit Payments (as defined in the TRA) that would have been payable to the TRA Parties pursuant to the TRA, but for the modification set forth in the TRA Amendment, will thereafter become payable to such TRA
Parties in accordance with the terms of the TRA.

Listing of Clearwater Common Stock; Delisting of Enfusion Common Stock

It is a condition to the completion of the Transactions that the shares of Clearwater Common Stock to be issued to Enfusion
Stockholders in the Transactions be approved for listing on New York Stock Exchange, subject to official notice of issuance. As a result of the Transactions, shares of Enfusion Common Stock will cease to be listed on the New York Stock Exchange.

Shares of Enfusion Common Stock currently trade on the NYSE under the stock symbol “ENFN.” When the Transactions are completed,
Enfusion Common Stock currently listed on the NYSE will cease to be quoted on the NYSE and will be deregistered under the Exchange Act.

112

THE MERGER AGREEMENT

The following description sets forth the principal terms of the Merger Agreement, which is attached asAnnex Aand incorporated by reference into this Proxy Statement/Prospectus. The rights and obligations of the parties to the Merger Agreement are governed by the express terms and conditions of the Merger Agreement and not by this description, which is summary by nature, or by any other description of the Merger Agreement in this Proxy Statement/Prospectus. This description does not purport to be complete, may not contain all of the information about the Merger Agreement that is important to you and is qualified in its entirety by reference to the complete text of the Merger Agreement. You are encouraged to read the Merger Agreement carefully and in its entirety, as well as this Proxy Statement/Prospectus, before making any decisions regarding any of the proposals described in this Proxy Statement